Interview: John O’Hara – General Manager, Janssen Puerto Rico
John O’Hara is the general manager and vice president of Janssen’s facilities in Puerto Rico as well as the head of the Janssen campus. He discusses the affiliate’s rapid growth…
Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.
Our ultimate goal is to help people live healthy lives. We have produced and marketed many first-in-class prescription medications and are poised to serve the broad needs of the healthcare market – from patients to practitioners, from clinics to hospitals.
Headquartered in Titusville, New Jersey, Janssen is named after Dr. Paul Janssen, a leading Belgian researcher, pharmacologist, and general practitioner. Dr. Janssen led a group of researchers to discover a medicine that helped change the way mental health patients were treated. His company, Janssen Pharmaceutica, joined the Johnson & Johnson family of companies in 1961. Our company remains guided by Dr. Janssen’s values of excellence and innovation.
Contact details
Bo. Mamey
Carr. 933 Km 0.1
Gurabo, PR 00778-9629
USA
Tel : 787-272-7600
www.janssen.com
John O’Hara is the general manager and vice president of Janssen’s facilities in Puerto Rico as well as the head of the Janssen campus. He discusses the affiliate’s rapid growth…
Giuseppe Allocca, Pfizer’s site leader for its Vega Baja & Barceloneta operations in Puerto Rico, highlights the importance of Pfizer’s manufacturing operations on the island, with 14 of the company’s…
Lucy Crespo, CEO of the Puerto Rico Science, Technology & Research Trust, takes stock of the Trust’s main achievements since outlining its strategic plan in 2015. She also highlights her…
After climbing through the ranks from sales representative to leading business units at Eli Lilly Canada, François Gilbert took the reins of Eli Lilly’s Puerto Rican affiliate last year. Among…
Charil Pabón, Owner & President of Pharma Consulting Corporation (PCC), explains how the decreasing demand for validation services in Puerto Rico prompted the company to expand in new business areas…
Puerto Rico has long been known for its pharma manufacturing prowess, but multinational companies are increasingly looking to conduct clinical trials there, thanks to strong institutional support, a strong example…
Leobardo Hidalgo, who lived in Puerto Rico as a child, recently came back to the island to head commercial operations at the local BMS affiliate, which has been performing remarkably…
Lcdo. Juan Santiago – EIT, President of the Colegio de Químicos Puerto Rico, explains the far-reaching role of chemists in Puerto Rico’s industry, their current challenges and the goal of…
Ricardo Zayas of US manufacturer Romark, highlights the company’s ambition to make Puerto Rico its operations and manufacturing headquarters. Currently in the scale-up phase, Zayas aims to expand the capacities…
David Foster, president and co-founder of Isla Pharmaceuticals, explains the rationale behind selecting Puerto Rico as a base for the company, which aims to develop treatments for mosquito-borne disease. He…
Dr David Lenihan, president of Ponce Health Sciences University (PHSU) in Puerto Rico, highlights the crucial role the institution plays in tackling the cultural deficit in healthcare on the US…
Iris and Tom Vincent, president and vice president of Prime Air Corp, discuss how the pharma and medical devices logistics company is growing by more than 20 percent per year…
Rolando Medina, managing director of operations at FedEx Express Puerto Rico, explains how FedEx Express is positioning itself as the partner of choice for the pharmaceutical industry by investing in…
See our Cookie Privacy Policy Here
